Bipolar Disorder Therapeutics Market Size

Bipolar Disorder Therapeutics Market size was over USD 5.97 billion in 2023 and is poised to exceed USD 8.99 billion by 2036, growing at over 3.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of bipolar disorder therapeutics is evaluated at USD 6.12 billion.

Rising of bipolar disorder, high unmet medical needs, technological advancement, and government initiatives are expected to drive the market over the forecast period. A significant number of people suffering from this mental condition resort to drinking to lift their mood.  According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse. Factors such as an increment in investment in research and development and collaboration activities between companies are estimated to propel the growth of bipolardisorder therapeutics market. On the other hand, advancements related to combination therapies of drugs provide lucrative opportunities for market growth in the near future.